Cell and Gene Therapy Market By Therapy Type (Cell Therapy, Gene Therapy, Germ-line Gene Therapy (GGT), Somatic Cell Gene Therapy (SCGT)), By Indication (Oncology, Genetic Disorders, Neurological Disorders, Cardiovascular Disorders, Infectious Diseases, Dermatology, Orthopaedics, Others), By Delivery Method (In Vivo, Ex Vivo), By End-User (Hospitals, Academic & Research Institutes, Cancer Care Centers, Pharmaceutical & Biotechnology Companies, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Aug 2025
- Report ID: 101909
- Number of Pages: 285
- Format:
-
keyboard_arrow_up
-
-
- GalaxoSmithKline plc
- Novartis AG
- Amgen Inc.
- Bristol-Myers Squibb Company
- Spark Therapeutics
- Pfizer Inc.
- Biogen Inc.
- Thermo Fisher Scientific Inc.
- Other Key Players
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible